FDA inspection

Neuraxpharm Pharmaceutical S.L: FDA inspection ending Sep 18, 2015

FDA inspection 944025 · Voluntary Action Indicated (VAI) · Sant Joan Despi

Key facts

Inspection ID 944025
Firm Neuraxpharm Pharmaceutical S.L
FEI number 3003232455
Address Avenida Barcelona 69
City Sant Joan Despi
Country Spain
Fiscal year 2015
Inspection end date Sep 18, 2015
Classification Voluntary Action Indicated (VAI)
Project area Drug Quality Assurance
Product type Drugs

At a glance

  • 1–9 Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections